|
Delayed
OTC Markets
23:34:48 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0261 USD | -9.06% |
|
+0.40% | -3.46% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAPY 0.0261 $
-9.06%
628.25
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAPY | 0.0261USD | -9.06% | 628.25 $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 23/10/2026 | 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | |
|---|---|---|---|---|---|
| Last | US$0.0300 | US$0.0251 | US$0.0289 | US$0.0287 | US$0.0261 |
| Volume | 41,951 | 340,808 | 43,846 | 45,769 | 24,071 |
| Change | +20.00% | -16.33% | +15.14% | -0.69% | -9.06% |
| Opening | US$0.0316 | US$0.0250 | US$0.0250 | US$0.0250 | US$0.0287 |
| High | US$0.0316 | US$0.0300 | US$0.0299 | US$0.0289 | US$0.0287 |
| Low | US$0.0250 | US$0.0250 | US$0.0250 | US$0.0250 | US$0.0251 |
Performance
| 1 day | -12.54% | ||
| 1 week | +0.40% | ||
| Current month | -33.95% | ||
| 1 month | -3.46% | ||
| 3 months | -21.56% | ||
| 6 months | +25,000.00% | ||
| Current year | -3.46% | ||
| 1 year | -54.28% | ||
| 3 years | -95.48% | ||
| 5 years | -99.50% | ||
| 10 years | -99.42% |
Volumes
marketsDaily volume
24,071
Estimated daily volume
75,031
Avg. Volume 20 sessions
185,218
Daily volume ratio
0.41
Avg. Volume 20 sessions USD
4,834.19
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
7,606,980
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03%
Free-Float capitalization (USD)
6,401,367
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.0275
Moving average 20 days
0.031
Moving average 50 days
0.0277
Moving average 100 days
0.0305
Price spread / (MMA5)
+5.36%
Price spread / (MMA20)
+18.77%
Price spread / (MMA50)
+6.13%
Price spread / (MMA100)
+16.86%
STIM
RSI 9 days
48.75
RSI 14 days
49.46
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.06% | +0.40% | -54.28% | -95.48% | 7.61M | |
| +6.17% | +4.43% | +67.73% | +141.21% | 1,148B | |
| +1.52% | +2.74% | +47.35% | +87.01% | 652B | |
| +1.25% | +1.60% | +28.69% | +104.20% | 505B | |
| +0.79% | +2.55% | +54.42% | +66.64% | 384B | |
| +4.44% | +0.33% | +70.62% | +43.87% | 348B | |
| +2.55% | +2.87% | +34.60% | +56.66% | 294B | |
| +2.08% | +0.49% | +3.85% | +27.66% | 264B | |
| +1.72% | +2.88% | +57.71% | +74.83% | 244B | |
| +1.38% | +2.77% | +36.33% | +107.73% | 197B | |
| Average | +0.94% | +0.22% | +34.70% | +61.43% | 403.72B | |
| Weighted average by Cap. | +3.09% | +1.50% | +49.81% | +93.12% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
0cb8a9c6a68c4f0c5aaa0594b.-OH3ZMHtadvXUB4qI6lEoqSPgGRM-qa1CNF2P8YRYf8.kczCLamjUJeiHVdPEOgU7eH-zAAgl8f3XYguevMmD5ei1IZJ9dofquMeRw
| Date | Price | Volume | Total |
|---|---|---|---|
| 23:34:48 | 0.0261 | 6,800 | 23,988 |
| 23:34:47 | 0.0261 | 100 | 17,188 |
| 23:32:08 | 0.0251 | 3,000 | 17,088 |
| 23:18:22 | 0.0287 | 100 | 14,088 |
| 23:16:29 | 0.0251 | 120 | 13,988 |
| 23:03:37 | 0.0251 | 302 | 13,868 |
| 22:47:17 | 0.0287 | 100 | 13,566 |
| 22:39:38 | 0.0251 | 420 | 13,466 |
| 22:24:17 | 0.0251 | 1,000 | 13,046 |
| 22:17:29 | 0.0287 | 100 | 12,046 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0 | | 0.04 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.07 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | +10.38% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
